In vitro perfusion of engineered heart tissue through endothelialized channels

Tissue Engineering - Part A

Volumn 20, Issue 3-4, 2014, Pages 854-863

  Vollert, Ingra ^a,b   Seiffert, Moritz ^a,b,c   Bachmair, Johanna ^d,e   Sander, Merle ^a,b   Eder, Alexandra ^a,b   Conradi, Lenard ^a,b,c   Vogelsang, Alexander ^a,b   Schulze, Thomas ^a,b   Uebeler, June ^a,b   Holnthoner, Wolfgang ^d   Redl, Heinz ^d   Reichenspurner, Hermann ^a,b,c   Hansen, Arne ^a,b   Eschenhagen, Thomas ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY HEART CENTER HAMBURG   (Germany)

^d LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^e VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELLS; HEART; OXYGEN SUPPLY; SILICONES;

CARDIAC MUSCLES; CARDIAC TISSUES; CONTINUOUS PERFUSIONS; CROSS SECTIONAL AREA; ENGINEERED HEART TISSUES; FIBRIN POLYMERIZATIONS; OXYGEN CONCENTRATIONS; TUBULAR STRUCTURES;

TISSUE;

ALGINIC ACID; DYSTROPHIN; FIBRIN; OXYGEN; SILICONE; THROMBIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENGINEERED HEART TISSUE; FIBRIN POLYMERIZATION; HEART CONTRACTION; HEART MUSCLE CELL; IN VITRO STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROCEDURES; RAT; SENSOR; TISSUE ENGINEERING; TISSUE PERFUSION;

ALGINATES; ANIMALS; CATTLE; CITRATES; DYSTROPHIN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLUCURONIC ACID; HEART; HEXURONIC ACIDS; OXYGEN; PERFUSION; RATS; TISSUE ENGINEERING;

EID: 84894178377     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0214     Document Type: Article

References (43)

1. Eschenhagen, T., Eder, A., Vollert, I., and Hansen, A. Physiological aspects of cardiac tissue engineering. Am J Physiol Heart Circ Physiol 303, H133, 2012.
2. Huang, G.Y., Zhou, L.H., Zhang, Q.C., Chen, Y.M., Sun, W., Xu, F., and Lu, T.J. Microfluidic hydrogels for tissue engineering. Biofabrication 3, 012001, 2011.
3. Radisic, M., Malda, J., Epping, E., Geng, W., Langer, R., and Vunjak-Novakovic, G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Bio-technol Bioeng 93, 332, 2006.
4. Carrier, R.L., Rupnick, M., Langer, R., Schoen, F.J., Freed, L.E., and Vunjak-Novakovic, G. Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng 8, 175, 2002.
5. Kaneko, N., Matsuda, R., Toda, M., and Shimamoto, K. Three-dimensional reconstruction of the human capillary network and the intramyocardial micronecrosis. Am J Phy-siol Heart Circ Physiol 300, H754, 2011.
6. Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I.H.M., Gepstein, L., and Levenberg, S. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 100, 263, 2007.
7. Engelmayr, G.C., Cheng, M., Bettinger, C.J., Borenstein, J.T., Langer, R., and Freed, L.E. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater 7, 1003, 2008.
8. Ott, H.C., Matthiesen, T.S., Goh, S.-K., Black, L.D., Kren, S.M., Netoff, T.I., and Taylor, D.A. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14, 213, 2008.
9. Tee, R., Morrison, W.A., Dusting, G.J., Liu, G., Choi, Y.S., Hsiao, S.T., and Dilley, R.J. Transplantation of engineered cardiac muscle flaps in syngeneic rats. Tissue Eng Part A 18, 1992, 2012.
10. Sekine, H., Shimizu, T., Sakaguchi, K., Dobashi, I., Wada, M., Yamato, M., Kobayashi, E., Umezu, M., and Okano, T. In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nat Commun 4, 1399, 2013.
11. Shimizu, T. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90, 40e, 2002.
12. Asakawa, N., Shimizu, T., Tsuda, Y., Sekiya, S., Sasagawa, T., Yamato, M., Fukai, F., and Okano, T. Pre-vascularization of in vitro three-dimensional tissues created by cell sheet engineering. Biomaterials 31, 3903, 2010.
13. Shimizu, T., Sekine, H., Yang, J., Isoi, Y., Yamato, M., Ki-kuchi, A., Kobayashi, E., and Okano, T. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J 20, 708, 2006.
14. Freeman, I., and Cohen, S. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 30, 2122, 2009.
15. Lesman, A., Habib, M., Caspi, O., Gepstein, A., Arbel, G., Levenberg, S., and Gepstein, L. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A 16, 115, 2010.
16. Tulloch, N.L., Muskheli, V., Razumova M V, Korte, F.S., Regnier, M., Hauch, K.D., Pabon, L., Reinecke, H., and Murry, C.E. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 109, 47, 2011.
17. Radisic, M., Marsano, A., Maidhof, R., Wang, Y., and Vun-jak-Novakovic, G. Cardiac tissue engineering using perfu-sion bioreactor systems. Nat Protoc 3, 719, 2008.
18. Chiu, L.L.Y., Montgomery, M., Liang, Y., Liu, H., and Ra-disic, M. Perfusable branching microvessel bed for vascu-larization of engineered tissues. Proc Natl Acad Sci USA 109, E3414, 2012.
19. Marsano, A., Maidhof, R., Luo, J., Fujikara, K., Konofagou, E.E., Banfi, A., and Vunjak-Novakovic, G. The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction. Biomaterials 34, 393, 2013.
20. Hansen, A., Eder, A., Bönstrup, M., Flato, M., Mewe, M., Schaaf, S., Aksehirlioglu, B., Schwörer, A., Uebeler, J., and Eschenhagen, T. Development of a drug screening platform based on engineered heart tissue. Circ Res 107, 35, 2010.
21. Conradi, L., Pahrmann, C., Schmidt, S., Deuse, T., Hansen, A., Eder, A., Reichenspurner, H., Robbins, R.C., Eschenha-gen, T., and Schrepfer, S. Bioluminescence imaging for assessment of immune responses following implantation of engineered heart tissue (EHT). J Vis Exp 52, 2011. DOI: 10.3791/2605.
22. Zimmermann, W.H., Fink, C., Kralisch, D., Remmers, U., Weil, J., and Eschenhagen, T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68, 106, 2000.
23. Lovett, M., Lee, K., Edwards, A., and Kaplan, D.L. Vascu-larization strategies for tissue engineering. Tissue Eng Part B Rev 15, 353, 2009.
24. Atala, A., Kasper, F.K., and Mikos, A.G. Engineering complex tissues. Science Transl Med 4, 1, 2012.
25. Boron, W.F., and Boulpaep, E.L. Medical Physiology. 2nd Revise. Philadelphia: Saunders, 2008.
26. Naito, H., Melnychenko, I., Didié, M., Schneiderbanger, K., Schubert, P., Rosenkranz, S., Eschenhagen, T., and Zim-mermann, W.-H. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114, I72, 2006.
27. Folkman, J., and Haudenschild, C. Angiogenesis in vitro. Nature 288, 551, 1980.
28. Takei, T., Sakai, S., Yokonuma, T., Ijima, H., and Kawakami, K. Fabrication of artificial endothelialized tubes with predetermined three-dimensional configuration from flexible cell-enclosing alginate fibers. Biotechnol Prog 23, 182, 2007.
29. Sakai, S., Yamaguchi, S., Takei, T., and Kawakami, K. Oxidized alginate-cross-linked alginate/gelatin hydrogel fibers for fabricating tubular constructs with layered smooth muscle cells and endothelial cells in collagen gels. Bioma-cromolecules 9, 2036, 2008.
30. Becker, T.A., Kipke, D.R., and Brandon, T. Calcium alginate gel: a biocompatible and mechanically stable polymer for endovascular embolization. J Biomed Mater Res 54, 76, 2001.
31. Cohen, J., Zaleski, K.L., Nourissat, G., Julien, T.P., Randolph, M.A., and Yaremchuk, M.J. Survival of porcine mesenchy-mal stem cells over the alginate recovered cellular method. J Biomed Mater Res A 96, 93, 2011.
32. Ballal, N.V., Kundabala, M., Bhat, S., Rao, N., and Rao BSS. A comparative in vitro evaluation of cytotoxic effects of EDTA and maleic acid: root canal irrigants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108, 633, 2009.
33. Cai, Z.H., Shi, Z.Q., Sherman, M., and Sun, A.M. Development and evaluation of a system of microencapsulation of primary rat hepatocytes. Hepatology 10, 855, 1989.
34. De Groot, M., Leuvenink, H.G.D., Keizer, P.P.M., Fekken, S., Schuurs, T.A., and Van Schilfgaarde, R. Technical Note Effective removal of alginate-poly-L-lysine microcapsules from pancreatic islets by use of trypsin-EDTA. J Biomed Mater Res A 67, 679, 2003.
35. Sakaguchi, K., Shimizu, T., Horaguchi, S., Sekine, H., Ya-mato, M., Umezu, M., and Okano, T. In vitro engineering of vascularized tissue surrogates. Sci Rep 3, 1316, 2013.
36. Shepherd, B.R., Chen, H.Y.S., Smith, C.M., Gruionu, G., Williams, S.K., and Hoying, J.B. Rapid perfusion and network remodeling in a microvascular construct after implantation. Arterioscler Thromb Vasc Biol 24, 898, 2004.
37. Eschenhagen, T., Fink, C., Remmers, U., Scholz, H., Wattchow, J., Weil, J., Zimmermann, W., Dohmen, H.H., Schäfer, H., Bishopric, N., Wakatsuki, T., and Elson, E.L. Three-dimensional reconstitution of embryonic cardio-myocytes in a collagen matrix: a new heart muscle model system. FASEB J 11, 683, 1997.
38. Fink, C., Ergün, S., Kralisch, D., Remmers, U., Weil, J., and Eschenhagen, T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J 14, 669, 2000.
39. Radisic, M., Deen, W., Langer, R., and Vunjak-Novakovic, G. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol 288, H1278, 2005.
40. Davies, P.F. Flow-mediated endothelial mechanotransduc-tion. Physiol Rev 75, 519, 1995.
41. Holnthoner, W., Hohenegger, K., Husa, A., Muehleder, S., Meinl, A., Peterbauer-Scherb, A., and Redl, H. Adipose-derived stem cells induce vascular tube formation of outgrowth endothelial cells in a fibrin matrix. J Tissue Eng Regen Med 2012. DOI: 10.1002/term.1620.
42. Hoying, J.B., Boswell, C.A., and Williams, S.K. Angiogenic potential of microvessel fragments established in three-dimensional collagen gels. In Vitro Cell Dev Biol Anim 32, 409, 1996.
43. L'Heureux, N., Dusserre, N., Konig, G., Victor, B., Keire, P., Wight, T.N., Chronos, N.A.F., Kyles, A.E., Gregory, C.R., Hoyt, G., Robbins, R.C., and McAllister, T.N. Human tissue-engineered blood vessels for adult arterial revascu-larization. Nat Med 12, 361, 2006.